Boston Scientific (BSX) Raw Materials (2009 - 2026)

Boston Scientific's Raw Materials history runs 18 years deep, the most recent figure standing at $928.0 million for Q1 2026.

• In Q1 2026, Raw Materials rose 10.08% year-over-year to $928.0 million; the TTM figure through Mar 2026 stood at $928.0 million (up 10.08% YoY), while the FY2025 annual figure was $849.0 million, up 3.66% from the prior year.
• Raw Materials came in at $928.0 million for Q1 2026 at Boston Scientific, up from $849.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $928.0 million in Q1 2026 to a low of $499.0 million in Q1 2022.
• A 5-year average of $743.2 million and a median of $818.0 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials jumped 41.09% in 2023 and decreased 1.65% in 2025, its largest moves.
• Boston Scientific's Raw Materials stood at $548.0 million in 2022, then surged by 41.06% to $773.0 million in 2023, then gained by 5.95% to $819.0 million in 2024, then advanced by 3.66% to $849.0 million in 2025, then increased by 9.31% to $928.0 million in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $928.0 million, $849.0 million, and $849.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison